Shunhai Wang

机构：Regeneron (United States) · ORCID：0000-0003-4055-2187

发表论文 66 篇 · 总被引 997 次 · h-index 17

代表论文

• A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies (2024 · Cell Reports Medicine · 被引 27)
• Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mapping (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 16)
• Characterization of adeno-associated virus capsid proteins using denaturing size-exclusion chromatography coupled with mass spectrometry (2024 · Journal of Pharmaceutical and Biomedical Analysis · 被引 9)
• Development of a Flow Through-Based Limited Digestion Approach for High-Throughput and High-Sequence Coverage Mapping of Therapeutic mRNAs (2024 · Analytical Chemistry · 被引 9)
• Affinity-Resolved Size Exclusion Chromatography Coupled to Mass Spectrometry: A Novel Tool to Study the Attribute-and-Function Relationship in Therapeutic Monoclonal Antibodies (2024 · Analytical Chemistry · 被引 9)
• An Online Native Mass Spectrometry Approach for Fast, Sensitive, and Quantitative Assessment of Adeno-Associated Virus Capsid Content Ratios (2024 · Journal of the American Society for Mass Spectrometry · 被引 9)